140 related articles for article (PubMed ID: 33791490)
1. Use of DECAF scoring system to facilitate early discharge in acute exacerbation of COPD patients: a quality improvement project at a district general hospital.
Nadeem I; Light A; Donaldson C; Khatana UF; Bagmane D; Thomas E; Azher M
Future Healthc J; 2021 Mar; 8(1):e123-e126. PubMed ID: 33791490
[TBL] [Abstract][Full Text] [Related]
2. Role of the DECAF Score in Predicting In-hospital Mortality in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Memon MA; Faryal S; Brohi N; Kumar B
Cureus; 2019 Jun; 11(6):e4826. PubMed ID: 31403014
[TBL] [Abstract][Full Text] [Related]
3. An International Validation of the "DECAF Score" to Predict Disease Severity and Hospital Mortality in Acute Exacerbation of COPD in the UAE.
Almarshoodi K; Echevarria C; Kassem A; Mahboub B; Salameh L; Ward C
Hosp Pharm; 2024 Apr; 59(2):234-240. PubMed ID: 38450352
[TBL] [Abstract][Full Text] [Related]
4. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; He C; Xiong H; Shuai T; Zhang C; Zhang M; Wang Y; Zhu L; Lu J; Jian L
BMJ Open; 2020 Oct; 10(10):e037923. PubMed ID: 33127631
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality in acute exacerbations of chronic obstructive pulmonary disease using the dyspnea, eosinopenia, consolidation, acidemia and atrial fibrillation score.
Bansal AG; Gaude GS
Lung India; 2020; 37(1):19-23. PubMed ID: 31898616
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin (PCT) Improves the Accuracy and Sensitivity of Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation (DECAF) Score in Predicting AECOPD Patients Admission to ICU.
Chen Y; Li LIQ; Ge YL; Hu XY; Zhang Q; Zhang HF; Li WQ; Zhang S; Zhu XY; Zhang JB
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162862
[TBL] [Abstract][Full Text] [Related]
7. The v-DECAF score can predict 90-day all-cause mortality in patients with COPD exacerbation requiring invasive mechanical ventilation.
Shi QF; Sheng Y; Zhu N; Tan Y; Xie XH; Wang SY; Cai JF
Clin Respir J; 2019 Jul; 13(7):438-445. PubMed ID: 30955228
[TBL] [Abstract][Full Text] [Related]
8. Utility of the DECAF score for predicting survival of patients with COPD: a meta-analysis of diagnostic accuracy studies.
Shen MH; Qiu GQ; Wu XM; Dong MJ
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4037-4050. PubMed ID: 34156682
[TBL] [Abstract][Full Text] [Related]
9. DECAF versus CURB-65 to Foresee Mortality among Patients Presenting with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Ahmed N; Jawad N; Jafri S; Raja W
Cureus; 2020 Jan; 12(1):e6613. PubMed ID: 32064193
[TBL] [Abstract][Full Text] [Related]
10. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD.
Echevarria C; Steer J; Heslop-Marshall K; Stenton SC; Hickey PM; Hughes R; Wijesinghe M; Harrison RN; Steen N; Simpson AJ; Gibson GJ; Bourke SC
Thorax; 2016 Feb; 71(2):133-40. PubMed ID: 26769015
[TBL] [Abstract][Full Text] [Related]
11. Performance of risk scores in patients with acute exacerbations of COPD.
Gomes L; Pereira S; Sousa-Pinto B; Rodrigues C
J Bras Pneumol; 2023; 49(5):e20230032. PubMed ID: 37909549
[TBL] [Abstract][Full Text] [Related]
12. Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation.
Echevarria C; Gray J; Hartley T; Steer J; Miller J; Simpson AJ; Gibson GJ; Bourke SC
Thorax; 2018 Aug; 73(8):713-722. PubMed ID: 29680821
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two scores for short-term outcomes in patients with COPD exacerbation in the emergency department: the Ottawa COPD Risk Scale and the DECAF score.
Unal A; Bayram B; Ergan B; Can K; Ergun YK; Kilinc O
ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 36923568
[TBL] [Abstract][Full Text] [Related]
14. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score.
Echevarria C; Steer J; Bourke SC
Thorax; 2019 Oct; 74(10):941-946. PubMed ID: 31387892
[TBL] [Abstract][Full Text] [Related]
15. Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, BAP-65, PLR, NLR.
Gayaf M; Karadeniz G; Güldaval F; Polat G; Türk M
Expert Rev Respir Med; 2021 Jun; 15(6):845-851. PubMed ID: 33691562
[No Abstract] [Full Text] [Related]
16. Comparing severity scores in exacerbations of chronic obstructive pulmonary disease.
Shafuddin E; Chang CL; Hancox RJ
Clin Respir J; 2018 Dec; 12(12):2668-2675. PubMed ID: 30471191
[TBL] [Abstract][Full Text] [Related]
17. Monocyte distribution width (MDW) and DECAF: two simple tools to determine the prognosis of severe COPD exacerbation.
Amado CA; Ghadban C; Manrique A; Osorio JS; Ruiz de Infante M; Perea R; Gónzalez-Ramos L; García-Martín S; Huidobro L; Zuazaga J; Druet P; Argos P; Poo C; Muruzábal MJ; España H; Andretta G
Intern Emerg Med; 2024 May; ():. PubMed ID: 38722501
[TBL] [Abstract][Full Text] [Related]
18. Comparison of BAP65, DECAF, PEARL, and MEWS Scores in Predicting Respiratory Support Need in Hospitalized Exacerbation of Chronic Obstructive Lung Disease Patients.
Acet-Öztürk NA; Aydin-Güçlü Ö; Yildiz MN; Demirdöğen E; Görek Dilektaşli A; Coşkun F; Uzaslan E; Ursavaş A; Karadağ M
Med Princ Pract; 2024 Apr; ():1-9. PubMed ID: 38626747
[TBL] [Abstract][Full Text] [Related]
19. Dyspnea, Eosinopenia, Consolidation, Acidemia and Atrial Fibrillation Score and BAP-65 Score, Tools for Prediction of Mortality in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Comparative Pilot Study.
Sangwan V; Chaudhry D; Malik R
Indian J Crit Care Med; 2017 Oct; 21(10):671-677. PubMed ID: 29142379
[TBL] [Abstract][Full Text] [Related]
20. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
